The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study

Trial Profile

The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Dexamethasone; Fluorouracil
  • Indications Glaucoma; Wounds
  • Focus Therapeutic Use
  • Acronyms RAFTS
  • Most Recent Events

    • 10 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top